Glucagon-like peptide-1 analogues and the risk of diabetic retinopathy.

Glucagon-like peptide-1 analogues and the risk of diabetic retinopathy.

Douros A, Filion KB, Yin H, Yu OH, Etminan M, Udell JA, Azoulay L. Glucagon-like peptide-1 analogues and the risk of diabetic retinopathy. Diabetes Care. 2018 Nov;41(11):2330-2338.

View All Publications